News

BioM's articles and press releases about the Bavarian biotechnology sector


Martinsried-based EpiQMAx acquired by Berlin-based MoleQlar

After the Martin­sried-based start-up EpiQMAx had to file for in­solv­ency in the third quarter of this year, the epi­gen­et­ics…

2.5 million euros for five research teams from Bavaria: Start-up competition m4 Award announces winners

2.5 mil­lion euros fund­ing for in­nov­at­ive pro­jects in bio­medi­cine.The re­search pro­jects ad­dress the top­ics: He­pat­it­is-B,…

QuantumDiamonds and Bonescreen win Bavarian Start?Zuschuss! funding

Quan­tumDia­monds con­vinced with its dia­mond-based sensors for vari­ous ap­plic­a­tions, Bon­escreen with its non-in­vas­ive med­ic­al…

Project funding by the Bavarian-Californian Technology Center - Deadline for project proposals, including the high-tech area of life sciences: 15 October 2023

Also: “vis­it­ing schol­ar­ships ar­ti­fi­cial in­tel­li­gence” (vsai) and spe­cial con­di­tions for AI-pro­pos­als (Hightech Agenda…

DxPx EU Conference in Munich: Get the BioM 50% discount

For the first time, DxPx EU Con­fer­ence is hos­ted in Mu­nich, Ger­many – Octo­ber 5th for a one day onsite event of ef­fect­ive…

Book your BIO-Europe pre-events now! Registration is open for the "Cluster-Tour to the Biotech Hub in Martinsried" and "Brainlab HQ Tour"

The busi­ness part­ner­ing con­fer­ence BIO-Europe 2023 will take place from Novem­ber 6 to 8, 2023 at the Mu­nich Ex­hib­i­tion Center. …

Max Planck Humboldt Research Award Winner Researches Key Mechanisms of the Bacterial Immune System with Würzburg Helmholtz Institute and Ludwig Maximilian University of Munich

Rotem Sorek from the Weiz­mann In­sti­tute of Science in Is­rael will re­ceive the Max Planck-Hum­boldt Re­search Award 2023, which is…

Veterinary pharmaceuticals company Zoetis buys adivo from Puchheim

U.S.-based veter­in­ary drug­maker Zo­et­is has ac­quired Adivo, a bi­otech com­pany de­vel­op­ing thera­peut­ic an­ti­bod­ies for…

Future Medicine Science Match in Berlin - get your free ticket now via BioM

Get your free tick­et now via BioM for the Fu­ture Medi­cine Science Match. To­geth­er with the Ber­lin In­sti­tute for Health of the…

MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer

MorphoSys AG re­ceived the U.S. Food and Drug Ad­min­is­tra­tion (FDA) gran­ted Fast Track des­ig­na­tion for tul­mi­metostat, for the…